A platform for collecting data on mood disorders

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The ENABLE platform aims to standardize data collection methods for individuals with mood disorders, including depression and bipolar disorder, to facilitate the identification of biomarkers. It provides a structured approach for deep clinical and neurobiological phenotyping, creating a recruitment pool for future clinical trials. Participants will complete clinical assessments and may provide biological samples and undergo neuroimaging procedures. This initiative seeks to enhance the understanding of mood disorders and improve treatment matching for affected individuals.

Why it matters

Who can join: the full rules

Inclusion Criteria

Patients:

1. 16 years of age or older.
2. Meet criteria for bipolar or depressive disorders as defined by DSM-5.
3. Fluency in English, sufficient to complete the interviews and self-report questionnaires.

Inclusion Criteria

Healthy Comparison (HC) Participants:

1. 16 years of age or older.
2. No history of psychiatric disorders (according to DSM-5) or significant unstable medical conditions.
3. Fluency in English, sufficient to complete the interviews and self-report questionnaires.

Where it's running

• University of Calgary
  Calgary, Alberta, Canada Recruiting
• University of British Columbia
  Vancouver, British Columbia, Canada Recruiting
• Nova Scotia Health Authority
  Halifax, Nova Scotia, Canada Recruiting
• McMaster University
  Hamilton, Ontario, Canada Recruiting
• Queen's University
  Kingston, Ontario, Canada Recruiting
• University of Ottawa
  Ottawa, Ontario, Canada Recruiting

Study contacts

• Principal investigator: Benicio N Frey — St. Joseph's Healthcare Hamilton
• Study coordinator: Saba Khoshroo
• Email: skhoshro@stjoes.ca
• Phone: 905-522-1155

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Testing a new drug for treatment-resistant depression

  This study is testing a new drug called HNK to see if it can help people with treatment-resistant depression feel better when other medications haven't worked.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT06511908

• A program to help young adults from minority groups engage with mental health services

  This study is testing a new program designed to help young adults from minority backgrounds connect better with mental health services by adding cultural insights and creative arts therapy.

  Recruiting New York University · The Bronx, New York · NCT06508450

• Investigating the effects of citalopram on brain response to emotions

  This study tests how the antidepressant citalopram affects the brain's response to emotions in healthy people by comparing brain scans after taking the medication or a placebo.

  Recruiting University of Oxford · Oxford, Oxfordshire · NCT06412315

• Understanding children's emotions in therapy

  This study is testing a new therapy approach for kids aged 8 to 15 with anxiety, depression, trauma, or behavior issues to see if it helps them feel better compared to those who aren't receiving treatment right away.

  Recruiting at 2 sites University of Guelph · Guelph, Ontario and 1 other locations · NCT05637320

• Cognitive-behavioral therapy and exercise training for teenage girls at risk for type 2 diabetes

  This study is testing if cognitive-behavioral therapy, exercise training, or both can help teenage girls at risk for type 2 diabetes improve their health and reduce stress and depression.

  Recruiting at 2 sites Colorado State University · Aurora, Colorado and 1 other locations · NCT05543083

• Understanding anxiety, depression, and bipolar disorder over time in China

  This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.

  Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07903246

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.